Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Summary Background Cancer research emphasises early detection, yet quantitative methods for analysing normal tissue remain limited. Hematoxylin and eosin (H&E)-stained tissues in digitised whole slide images (WSIs) enable computational histopathology; however, artificial intelligence (AI)-based analyses of normal breast tissue (NBT) remain scarce. Methods We curated 70 WSIs of NBTs from multiple sources with pathologist-guided manual annotations of epithelium, stroma, and adipocytes, and developed robust convolutional neural network (CNN)-based, patch-level classification models, named NBT-Classifiers , to tessellate and classify NBTs at different scales. Data and code are available at https://github.com/cancerbioinformatics/OASIS and https://github.com/cancerbioinformatics/NBT-Classifier . Findings Across three external cohorts, NBT-Classifiers trained on 128 x 128 µm and 256 x 256 µm patches achieved AUCs of 0·98–1·00. Two explainable artificial-intelligence (AI)- visualisation techniques confirmed the biological relevance of tissue class predictions. An end-to-end WSI pre-processing framework was then integrated, capable of localising lobules and peri-lobular stroma. The outputs are compatible with the QuPath v0.3.0 platform and enable downstream digital image analysis, such as texture and nuclei morphology assessment, at the patch level. Interpretation NBT-Classifiers represent a robust, generalisable, end-to-end deep learning framework, which will enable broader application in studies of normal tissues, in the context of breast and breast cancer. Funding The Breast Cancer Research Trust, Breast Cancer Now (and their legacy charity Breakthrough Breast Cancer), the Medical Research Council (MRC) [MR/X012476/1], Cancer Research UK [CRUK/07/012, KCL-BCN-Q3], and CRUK City of London Centre Award [CTRQQR-2021/100004]. Research in context Evidence before this study We searched PubMed from Jan 1, 2013, to Mar 20, 2025, using the query (("normal breast" OR "terminal duct lobular unit" OR "TDLU" OR "acini") AND ("artificial intelligence" OR "deep learning" OR "convolutional neural network" OR "CNN" OR "machine learning" OR "automation" OR "classification" OR "segmentation" OR "detection")) AND (journal article[pt] NOT review[pt]) NOT ("computed tomography" OR "CT" OR "ultrasound" OR "sonography" OR "US" OR "mammography" OR "mammogram" OR "Raman" OR "single-cell" OR "MRI"). This yielded 264 initial hits and after a thorough manual review, only eight studies were found to be relevant for using deep learning or machine learning to automate tissue recognition or quantification of normal breast tissues (NBTs) on digitised histological images. All these methods are highly specialised for detecting and quantifying lobules or quantifying tissue composition, and none of them are specifically tailored for providing patch-level tissue classifications on WSIs of NBTs. Moreover, NBTs are heavily underrepresented in large annotated WSI databases. A recent literatur